Report : A-Z HCD items in Formulary 02/04/2020 10:06:02

[Back]

Section Status HCD Name 05.03.01 Restricted Use Abacavir Ziagen® 05.03.01 Restricted Use Abacavir and Lamivudine and Zidovudine Trizivir® 10.01.03 Restricted Use Abatacept Orencia® 01.05.03 Restricted Use Adalimumab Humira® 13.05.03 Restricted Use Adalimumab Humira® 08.02.03 Formulary Alemtuzumab MabCampath® 10.01.03 Restricted Use Baricitinib Olumiant 03.01 Restricted Use benralizumab Fasenra 13.05.02 Formulary Brodalumab  10.03.01 Formulary Collagenase clostridium histolyticum  Xiapex® 13.05.03 Restricted Use Dupilumab Dupixent® 13.05.03 Restricted Use Etanercept Benapali® 13.05.03 Restricted Use Etanercept Enbrel ® 08.03.04.01 Restricted Use Fulvestrant Faslodex® 08.01.05 Restricted Use Ibrutinib Imbruvica® 20.01 Restricted Use Idelalisib 100mg and 150mg tablets Zydelig® 24.01 Formulary Immunoglobulins  13.05.03 Restricted Use lanadelumab Takhzyro 10.01.04 Non Formulary Lesinurad  03.04.02 Restricted Use Mepolizumab Nucala® 01.09.01 Formulary Obeticholic acid  Ocaliva® 03.04.02 Restricted Use Omalizumab Xolair® 24.16 Formulary Palivizumab Neonatal 08.01.05 Restricted Use Panitumumab ® 08.01.05 Restricted Use Pembrolizumab Keytruda® 03.11 Formulary Pirfenidone  24.16 Formulary Poractant alfa (Curosurf) Neonatal 03.04.02 Restricted Use Reslizumab  Cinqaero 03.03.03 Formulary Roflumilast Daxas 10.01.03 Restricted Use Sarilumab   10.01.03 Restricted Use Tofacitinib Xeljanz 08.01.05 Restricted Use Trastuzumab Herceptin® 08.01.05 Restricted Use Trastuzumab emtansine Kadcyla® 13.05.03 Formulary Ustekinumab Stelara® 08.01 Formulary Venetoclax Venclyxto®

Harrogate & Rural District Formulary